NCT04280874View on ClinicalTrials.gov

Induction of Labor in Term Pregnancies With Unfavourable Cervix

PHASE4CompletedINTERVENTIONAL
Enrollment

212

Participants

Timeline

Start Date

December 10, 2018

Primary Completion Date

July 1, 2020

Study Completion Date

July 1, 2020

Conditions
Induction of Labor Affected Fetus / NewbornProstaglandins Causing Adverse Effects in Therapeutic Use
Interventions
DRUG

Dinoprostone 0.5 MG

0.5mg dinoprostone applied intracervically

DRUG

Dinoprostone 2 MG/2.5 ML Vaginal Gel/Jelly

2mg dinoprostone applied intravaginally

Trial Locations (1)

1000

Clinical Hospital Merkur, Zagreb

All Listed Sponsors
lead

Clinical Hospital Merkur

OTHER

NCT04280874 - Induction of Labor in Term Pregnancies With Unfavourable Cervix | Biotech Hunter | Biotech Hunter